Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Second Physician Survey Supports Prescription Data: Expecting 1Q Fusilev Growth
Second Physician Survey Supports Prescription Data: Expecting 1Q Fusilev Growth
Second Physician Survey Supports Prescription Data: Expecting 1Q Fusilev Growth
Submitted by
admin
on April 17, 2012 - 10:42am
Source:
Seeking Alpha
News Tags:
Fusilev
physicians
Spectrum Pharmaceuticals
Allos
Teva Pharmaceuticals
Headline:
Second Physician Survey Supports Prescription Data: Expecting 1Q Fusilev Growth
Do Not Allow Advertisers to Use My Personal information
